To buy peptides for laboratory work reliably, a researcher needs to specify the sequence and modifications exactly, understand what the purity figure does and does not show, and require batch-specific analytical data before the material is used. Research peptides are synthetic amino acid chains, typically two to fifty residues long, made by solid-phase synthesis, purified by reversed-phase HPLC and supplied as lyophilised powders. Price and catalogue size say little about quality. This article explains what to specify when ordering, how counter-ions and net content affect results, what the methods literature shows, and how to check, store and handle material on arrival.
What does it mean to buy peptides for research?
A research peptide is defined by its supply route: it is made for laboratory use, not for clinical use, and it is sold with analytical data of varying depth. The specification for an order has several parts. The sequence should be written in standard one-letter or three-letter code, from the N-terminus to the C-terminus, and any modifications must be stated explicitly: N-terminal acetylation, C-terminal amidation, D-amino acids, cyclisation or disulfide bonds, non-natural residues, labels such as fluorophores or biotin, and phosphorylation or other post-translational modifications. Quantity, purity grade, salt form and the quality control package complete the order.
Purity grades are conventionally given as crude, above 80%, above 90%, above 95% and above 98%, each expressed as percentage peak area by HPLC. The grade should match the application: qualitative screening and antibody production often tolerate 85 to 95%, whereas quantitative receptor pharmacology, kinetics and analytical standards usually need 98% or more. Longer sequences are harder to synthesise, so higher grades cost more and may take longer.
A supplier relationship should be assessed in the same way as any reagent source. A professional supplier gives a company registration and address, a named technical contact, a safety data sheet, batch numbers on every vial, and a certificate of analysis for that batch. Warning signs include purity claims without a method, one generic certificate for many batches, no mass spectrometry data, “pharmaceutical grade” language for non-GMP material, and any wording that suggests human or veterinary use. UK laboratories have a further obligation under the Control of Substances Hazardous to Health (COSHH) Regulations to assess the chemicals they handle. Regulation of medicinal products in the UK turns on presentation and function, so a supplier’s marketing matters as well as its label. This article is general information, not legal advice.
Mechanism of action: how counter-ions and net content affect an assay
In purchasing, the mechanism that matters is how the composition of the vial acts on an experiment. Two features cause most problems: the counter-ion and the net peptide content.
Reversed-phase HPLC purification uses trifluoroacetic acid, so the isolated peptide is normally a trifluoroacetate (TFA) salt, in which TFA anions are bound to each basic group: the N-terminal amine, and the side chains of lysine, arginine and histidine. A peptide with several basic residues can therefore carry a substantial mass of counter-ion. The salt can be exchanged for acetate or hydrochloride by ion-exchange or repeated lyophilisation from dilute acid, a step that adds cost.
TFA is not inert in biological systems. Cornish and colleagues, working at the University of Auckland, reported in the American Journal of Physiology in 1999 that TFA at 10⁻⁸ to 10⁻⁷ M reduced cell numbers and thymidine incorporation in fetal rat osteoblast cultures after 24 hours, with similar effects in chondrocytes and neonatal mouse calvariae. When TFA and hydrochloride salts of amylin and calcitonin were compared in osteoblasts, proliferation was consistently lower with the TFA salts, which could cause a proliferative effect to be missed or an antiproliferative effect to be wrongly attributed to the peptide.
Net peptide content is the second variable. A vial labelled 5 mg contains peptide, counter-ions, residual water and sometimes salts, so the peptide itself may be 60 to 85% of that mass. A solution prepared from gross weight is therefore weaker than calculated by the same proportion. For a vial with 70% net content, 5 mg of powder contains about 3.5 mg of peptide, and every concentration, IC50 or EC50 derived from that solution is shifted accordingly. Quantifying net content by amino acid analysis or nitrogen analysis, and using it to prepare stock solutions, is a basic requirement for quantitative work.
What the research shows
Four sets of published work underpin how peptide quality is controlled and why it matters.
The first is the counter-ion study above. Cornish and colleagues’ paper showed in primary cell and organ cultures that a contaminant of purified peptides can alter proliferation at nanomolar concentrations, and it remains the standard citation for specifying acetate or hydrochloride salts in cell work. A record of the paper is held by the University of Manchester eScholar repository.
The second is the development of electrospray ionisation. John Fenn and colleagues showed in 1989 that electrospray could produce multiply charged ions from large biomolecules, so that their masses could be measured accurately by mass spectrometry. Fenn’s own account of how the method arose is available as an open-access article in PubMed Central. The technique is the basis of the intact mass confirmation that should appear on every certificate of analysis.
The third is a review of impurities. D’Hondt and colleagues published in the Journal of Pharmaceutical and Biomedical Analysis in 2014 a review of related impurities in peptide medicines, which classifies the by-products that arise during synthesis and storage, such as deletion and insertion sequences, incompletely deprotected products, racemised residues, and oxidised or deamidated forms. Although it concerns pharmaceutical peptides, the same impurity classes apply to research material.
The fourth is a methods study on salt exchange. Roux and colleagues evaluated different approaches to eliminating and exchanging the trifluoroacetate counter-ion from cationic peptides in the Journal of Peptide Science in 2008, which is the reference for the practical limits of salt exchange, including how completely TFA can be removed. Readers who need a specific salt form should ask the supplier how the exchange was done and how residual TFA was measured.
Research applications
What to require when buying depends on the use. For receptor pharmacology and cell signalling, high purity, an acetate or hydrochloride salt, a stated net peptide content and endotoxin testing matter most, because small amounts of active impurity or lipopolysaccharide can change dose-response curves. For enzyme and kinase assays, correct identity and the absence of truncated sequences are the main concern. For antibody production, the sequence and any carrier conjugation are critical, and moderate purity is often acceptable.
For analytical standards, the highest purity, full characterisation and a documented net content are needed, since the peptide defines the calibration. For structural and biophysical work, such as circular dichroism, NMR and fluorescence, the counter-ion matters because TFA absorbs in the far-ultraviolet and can distort spectra. For long projects, ordering one larger lot of a peptide, with a certificate and retained sample, gives better consistency than repeated small orders from different lots. Trial orders of a small quantity let a laboratory verify a new supplier’s material by its own HPLC and mass spectrometry before committing.
Receiving checks form part of the method. On arrival, the seal, label and batch number should be compared with the certificate, the date and condition recorded, and the vial moved straight to storage. If the data are critical, a laboratory can run its own HPLC and mass spectrometry on a small aliquot, compare the result with the certificate and keep both records with the experimental notebook.
Purity, storage and handling
Verification begins with reversed-phase HPLC, usually monitored at 214 nm for the peptide bond and at 280 nm for aromatic residues. The certificate should name the column, mobile phases, gradient and wavelength, and show the chromatogram, because purity quoted as a bare number cannot be checked. Mass spectrometry should confirm the intact mass against the theoretical value, and long peptides should be reported as deconvoluted masses from multiply charged ions. Amino acid analysis or nitrogen analysis gives net peptide content, and endotoxin testing is advisable for cell work.
Because degradation accelerates once reconstituted, batch-level HPLC verification matters more than a headline purity figure. Laboratories that buy peptides for cell-based or quantitative work should expect a batch-specific certificate of analysis and lyophilised storage at -20°C, and researchers asking How to buy best peptides can apply the same documentation checklist to every supplier they assess.
A batch-specific certificate matters because impurity profiles differ between synthesis runs even for the same sequence, and only a result tied to the batch number on the vial describes the material received. The certificate should show the batch number, analytical methods and conditions, observed mass, salt form, net peptide content, test date and recommended storage. Analysis by an independent laboratory working to ISO/IEC 17025 adds assurance, because it removes the possibility that a manufacturer is grading its own product, and raw chromatograms and spectra can be requested.
Lyophilised peptides are generally stored at -20°C, sealed and desiccated, with colder storage for long periods, and brought to room temperature before opening so that moisture does not condense on a hygroscopic powder. Short periods at ambient temperature during transit are usually tolerated by dry material. Reconstituted peptides are much less stable. Methionine and cysteine oxidise, asparagine and glutamine deamidate, aspartate-glycine and aspartate-proline sequences are labile, and hydrophobic or amphipathic peptides adsorb to plastic and aggregate. Stock solutions are therefore normally made in the supplier’s recommended diluent, kept at 2-8°C for short periods and divided into single-use aliquots to avoid repeated freeze-thaw cycles, with low-binding tubes preferred at low concentrations. Stability windows depend on sequence, buffer, pH and concentration, so they should be taken from supplier data and confirmed in-house for critical assays.
Light sensitivity depends on sequence. Peptides containing tryptophan, tyrosine or sulfur-containing residues can undergo photo-oxidation, so amber vials or dark storage are advisable for powder and solutions.
Frequently asked questions
What should I check before I buy peptides for research?
Check that the sequence and modifications match your specification, and that the supplier provides a batch-specific certificate of analysis with an HPLC chromatogram and its method, an observed mass, the salt form and net peptide content. Confirm that batch numbers match the vial, and that the supplier markets only for research use.
What does peptide purity percentage actually mean?
Purity is the proportion of the main peak in an HPLC chromatogram, measured by peak area at a stated wavelength. It does not show identity, net peptide content or counter-ion content, so it must be read with a mass spectrum and a net content figure. A peptide that is 98% pure may still be 70% peptide by weight.
Should I choose TFA, acetate or hydrochloride salt peptides?
For cell-based assays, acetate or hydrochloride salts are generally preferred, since trifluoroacetate was reported to reduce proliferation of osteoblasts and chondrocytes at nanomolar concentrations. For chemical or analytical work, TFA salts are usually acceptable. If only the TFA form is available, include a matched TFA vehicle control.
How should lyophilised peptides be stored on arrival?
Lyophilised peptides are generally stored at -20°C in a sealed, desiccated container protected from light, and warmed to room temperature before opening. Reconstituted solutions are usually kept at 2-8°C for short periods as single-use aliquots, with stability limits confirmed from batch documentation.
The peptides discussed in this article are supplied for in-vitro laboratory research only. They are not for human or veterinary use, and they must not be administered to people or animals.